Studies have demonstrated that mice with Imp2 deletion in mesenchymal stem cells (MSCs) exhibit resistance to diet-induced obesity without impairments in glucose and insulin tolerance, ultimately protecting against the development of type 2 diabetes (T2D). The gene discussed is IGF2BP2; the disease is type 2 diabetes mellitus.